Appendix 3Y Change of Director's Interest Notice
Appendix 3Y
Rule 3.19A.2
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity | Probiotec Limited |
ABN | 91 075 170 151 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Jonathan Wenig |
Date of last notice | 2 June 2020 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Indirect |
Nature of indirect interest | Linear Asset Management <> |
(including registered holder) | Pty Ltd A/C>, an entity associated with |
Note: Provide details of the circumstances giving rise to the relevant | |
interest. | Mr Wenig |
Date of change | 24 November 2020 |
No. of securities held prior to change | 47,500 |
Class | Fully Paid Ordinary |
Number acquired | 23,250 |
Number disposed | - |
Value/Consideration | $2.16 per share |
Note: If consideration is non-cash, provide details and estimated | |
valuation | |
No. of securities held after change | 70,750 |
- See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director's Interest Notice
Nature of change | On Market Trade |
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change
Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change
Part 3 - +Closed period
Were the interests in the securities or contracts detailed | No |
above traded during a +closed period where prior written | |
clearance was required? | |
If so, was prior written clearance provided to allow the trade | n/a |
to proceed during this period? | |
If prior written clearance was provided, on what date was this | n/a |
provided? | |
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 | 01/01/2011 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Probiotec Limited published this content on 26 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 November 2020 07:02:04 UTC